FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2117486518> ?p ?o ?g. }

• W2117486518 endingPage "153" @default.
• W2117486518 startingPage "147" @default.
• W2117486518 abstract "The current study was designed to investigate the hypocholesterolemic and anti-atherogenic properties of soy lecithin beyond its fatty acid content. In experiment 1, 18 cynomolgus monkeys were divided into three groups of six and fed diets which approximated either the average American diet (AAD), the American Heart Association (AHA) Step I diet, or a modified AHA (mAHA) Step I diet containing 3.4% soy lecithin for 8 weeks. Plasma samples were collected from food-deprived monkeys and analyzed for total cholesterol (TC), high-density lipoprotein cholesterol (HDL-C), very low- and low-density lipoprotein cholesterol (non-HDL-C), and triglyceride (TG) concentrations. Group comparisons revealed that monkeys fed the mAHA Step 1 diet had significantly lower plasma TC (-46%) and non-HDL-C (-55%) levels compared to the AAD diet, whereas monkeys fed the AHA Step 1 diet had lesser reductions in plasma TC (-21%) and non-HDL-C (-18%) levels. The monkeys fed the mAHA Step I diet had significantly lower plasma TC (-32%) and non-HDL-C (-45%) compared to the monkeys fed the AHA step diet. Also, only the mAHA Step I diet significantly reduced pre-treatment plasma TC and non-HDL-C levels by - 39 and -51% respectively with no significant effect on plasma HDL-C or TG levels. In experiment 2, 45 hamsters were divided into three groups of 15 and fed the following three modified non-purified diets for 8 weeks: a hypercholesterolemic diet (HCD) containing 10%, coconut oil and 0.05%, cholesterol, HCD plus 3.4%, soy lecithin (+SL), or the HCD with added levels of linoleate and choline equivalent to the +SL diet but no lecithin (-SL). Plasma lipids were determined as in experiment 1 and aortas were perfusion-fixed and Oil Red O stained for morphometric analyses of fatty streak area. Relative to the HCD group, the +SL-treated hamsters had significantly lower plasma TC (-58%), non-HDL-C (-73%) and aortic fatty streak area (-90%). Relative to the -SL group, hamsters fed the +SL diet had significantly lower plasma TC (-33%), non-HDL-C (-50%) and significantly reduced aortic fatty streak area (-79%). In conclusion, the first experiment suggests that the cholesterol-lowering efficacy of the AHA Step I diet can be enhanced with the addition of soy lecithin without reducing plasma HDL-C levels. whereas the second experiment suggest that the hypocholesterolemic, and in particular, the anti-atherogenic properties of soy lecithin cannot be attributed solely to its linoleate content." @default.
• W2117486518 created "2016-06-24" @default.
• W2117486518 creator A5055397658 @default.
• W2117486518 creator A5081181704 @default.
• W2117486518 creator A5084070062 @default.
• W2117486518 date "1998-09-01" @default.
• W2117486518 modified "2023-10-01" @default.
• W2117486518 title "Soy lecithin reduces plasma lipoprotein cholesterol and early atherogenesis in hypercholesterolemic monkeys and hamsters: beyond linoleate" @default.
• W2117486518 cites W1826281936 @default.
• W2117486518 cites W1848836653 @default.
• W2117486518 cites W1946263363 @default.
• W2117486518 cites W1966346071 @default.
• W2117486518 cites W2007072329 @default.
• W2117486518 cites W2015613764 @default.
• W2117486518 cites W2017265062 @default.
• W2117486518 cites W2032931158 @default.
• W2117486518 cites W2054998646 @default.
• W2117486518 cites W2077634722 @default.
• W2117486518 cites W2079480550 @default.
• W2117486518 cites W2104338850 @default.
• W2117486518 cites W2118313918 @default.
• W2117486518 cites W2120096031 @default.
• W2117486518 cites W2131529472 @default.
• W2117486518 cites W2136660973 @default.
• W2117486518 cites W2137804799 @default.
• W2117486518 cites W2150575708 @default.
• W2117486518 cites W2160327596 @default.
• W2117486518 cites W2171114008 @default.
• W2117486518 cites W2270372424 @default.
• W2117486518 cites W4249825849 @default.
• W2117486518 cites W4318599972 @default.
• W2117486518 cites W63860166 @default.
• W2117486518 doi "https://doi.org/10.1016/s0021-9150(98)00132-4" @default.
• W2117486518 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9733225" @default.
• W2117486518 hasPublicationYear "1998" @default.
• W2117486518 type Work @default.
• W2117486518 sameAs 2117486518 @default.
• W2117486518 citedByCount "85" @default.
• W2117486518 countsByYear W21174865182012 @default.
• W2117486518 countsByYear W21174865182013 @default.
• W2117486518 countsByYear W21174865182014 @default.
• W2117486518 countsByYear W21174865182015 @default.
• W2117486518 countsByYear W21174865182016 @default.
• W2117486518 countsByYear W21174865182017 @default.
• W2117486518 countsByYear W21174865182018 @default.
• W2117486518 countsByYear W21174865182019 @default.
• W2117486518 countsByYear W21174865182020 @default.
• W2117486518 countsByYear W21174865182021 @default.
• W2117486518 countsByYear W21174865182022 @default.
• W2117486518 countsByYear W21174865182023 @default.
• W2117486518 crossrefType "journal-article" @default.
• W2117486518 hasAuthorship W2117486518A5055397658 @default.
• W2117486518 hasAuthorship W2117486518A5081181704 @default.
• W2117486518 hasAuthorship W2117486518A5084070062 @default.
• W2117486518 hasConcept C126322002 @default.
• W2117486518 hasConcept C134018914 @default.
• W2117486518 hasConcept C185592680 @default.
• W2117486518 hasConcept C2777996180 @default.
• W2117486518 hasConcept C2778163477 @default.
• W2117486518 hasConcept C2778913445 @default.
• W2117486518 hasConcept C2779564620 @default.
• W2117486518 hasConcept C2780072125 @default.
• W2117486518 hasConcept C2780541478 @default.
• W2117486518 hasConcept C31903555 @default.
• W2117486518 hasConcept C55493867 @default.
• W2117486518 hasConcept C71924100 @default.
• W2117486518 hasConcept C86803240 @default.
• W2117486518 hasConceptScore W2117486518C126322002 @default.
• W2117486518 hasConceptScore W2117486518C134018914 @default.
• W2117486518 hasConceptScore W2117486518C185592680 @default.
• W2117486518 hasConceptScore W2117486518C2777996180 @default.
• W2117486518 hasConceptScore W2117486518C2778163477 @default.
• W2117486518 hasConceptScore W2117486518C2778913445 @default.
• W2117486518 hasConceptScore W2117486518C2779564620 @default.
• W2117486518 hasConceptScore W2117486518C2780072125 @default.
• W2117486518 hasConceptScore W2117486518C2780541478 @default.
• W2117486518 hasConceptScore W2117486518C31903555 @default.
• W2117486518 hasConceptScore W2117486518C55493867 @default.
• W2117486518 hasConceptScore W2117486518C71924100 @default.
• W2117486518 hasConceptScore W2117486518C86803240 @default.
• W2117486518 hasIssue "1" @default.
• W2117486518 hasLocation W21174865181 @default.
• W2117486518 hasLocation W21174865182 @default.
• W2117486518 hasOpenAccess W2117486518 @default.
• W2117486518 hasPrimaryLocation W21174865181 @default.
• W2117486518 hasRelatedWork W1976602105 @default.
• W2117486518 hasRelatedWork W1991390188 @default.
• W2117486518 hasRelatedWork W1993881492 @default.
• W2117486518 hasRelatedWork W2038672222 @default.
• W2117486518 hasRelatedWork W2072909849 @default.
• W2117486518 hasRelatedWork W2100236100 @default.
• W2117486518 hasRelatedWork W2118738696 @default.
• W2117486518 hasRelatedWork W2413861530 @default.
• W2117486518 hasRelatedWork W2977712257 @default.
• W2117486518 hasRelatedWork W4244653511 @default.
• W2117486518 hasVolume "140" @default.
• W2117486518 isParatext "false" @default.
• W2117486518 isRetracted "false" @default.

• next